Takeda Pays $13.7M to Settle False Claims Act Violations of Paying Kickbacks to Physicians
By the Constantine Cannon Whistleblower Team Last Thursday (May 14), the Department of Justice (DOJ) announced that Japan-based Takeda Pharmaceuticals agreed to pay roughly $13.7 million to settle allegations it violated the False Claims Act and Anti-Kickback Statute by paying kickbacks to healthcare providers to induce prescriptions of Takeda’s Trintellix antidepressant medication.[1] What Type of Kickbacks Did Takeda Allegedly Provide? The Anti‑Kickback Statute bars providing or receiving financial inducements to...